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Background: Despite the suggestion that the inflammatory response in traumatized children is functionally
unique, prognostic markers predicting pediatric multiple organ failure are lacking. We intended to verify whether
Interleukin-6 (IL-6) displays a pivotal role in pediatric trauma similar to adults.
Methods: Traumatized children less than 18 years of age with an Injury Severity Score >9 points and consecutive
admission to the hospital’s pediatric intensive care unit were included. Organ function was evaluated according to
the score by Marshall et al. while IL-6 levels were measured repetitively every morning.
Results: 59 traumatized children were included (8.4 ± 4.4 years; 57.6% male gender). Incidence of MODS was 11.9%.
No differences were found referring to age, gender, injury distribution or overall injury severity between children
with and without MODS. Increased IL-6 levels during hospital admission were associated with injury severity
(Spearman correlation: r = 0.522, p < 0.001), while an inconsistent association towards the development of MODS
was proven at that time point (Spearman correlation: r = 0.180, p = 0.231; Pearson's correlation: r = 0.297, p = 0.045).
However, increased IL-6 levels during the first two days were no longer associated with the injury severity but a
significant correlation to MODS was measured.
Conclusions: The presented prospective study is the first providing evidence for a correlation of IL-6 levels with
injury severity and the incidence of MODS in traumatized children.
Keywords: Multiple trauma, Pediatric trauma, Multiple organ dysfunction syndrome, Multiple organ failure, MODS,
Inflammatory response, Interleukin-6, IL-6Background
Trauma is known as leading cause of morbidity and mor-
tality in children older than one year of age [1,2]. Suffering
from severe injuries, children commonly sustain blunt
trauma mechanisms emphasizing on falls as well as pedes-
trian and cyclist motor vehicle impacts [3]. Due to differ-
ent anatomic characteristics compared to adults [4], injury
pattern differs sustaining especially life threatening head,
chest and abdominal injuries [5]. Despite this, children
suffering from multiple injuries have an improved survival* Correspondence: frink@med.uni-marburg.de
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article, unless otherwise stated.as compared to adults [6]. Nevertheless, although the inci-
dence of multiple organ failure (MODS) in pediatric trauma
patients is lower than in the adult population [7] an overall
mortality of 54% in pediatric MODS due to various reasons
was described [8,9]. Furthermore, children appear to deve-
lop MODS in a different temporal pattern than adults:
In children, MODS usually develops rapidly after ICU ad-
mission often within the first 4 to 7 days [9-11] suggesting
a relevant influence of the innate immune response to
trauma [10]. However, in adults, major trauma initiates a
two-fold compromise of the immune system with hyperin-
flammation in response to injury and subsequent immu-
nosupression [11,12]. Posttraumatic hyperinflammation
is characterized by local and systemic release of pro-
inflammatory cytokines, metabolites and acute phasentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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sponse syndrome (SIRS) [13,14]. Later, anti-inflammatory
mediators are released inducing immunosupression with
susceptibility to infection and septic complications during
the further clinical course [15]. The imbalance of this dual
immune response seems to be responsible for organ dys-
function and multiple organ failure in adults [13]. In order
to evaluate the severity of trauma and the risk for develop-
ing multiple organ failure, the pathophysiology of trauma
was analyzed to determine potential prognostic markers
[13,16]. Lately, Interleukin (IL-)6 as part of the pro-in-
flammatory cascade was verified as the most reliable prog-
nostic marker [17]. IL-6 correlates with injury severity
[18] as well as the incidence of multiple organ failure and
outcome [17,19].
While most of the studies were conducted in adults,
clinical data regarding the significance of cytokine levels
for pediatric trauma still do not exist [10]. Despite the
suggestion that the inflammatory response to major in-
jury in children is functionally unique [7,10], prognostic
markers predicting pediatric multiple organ failure are
missing. We therefore intended to verify whether IL-6
plays a pivotal role in pediatric trauma similar to trau-
matized adults.
Methods
The present study follows the guidelines of the revised UN
declaration of Helsinki in 1975 and its latest amendment
in 2008 (6th revision). The present study was approved by
the institutional ethical review board. No informed consent
was required. The study was performed at the Hannover
Medical School, Hannover, Germany.
Setting and patients
Traumatized children primarily admitted to a level I
trauma center during a four-year period between January
1st 2005 and December 31st 2008 were eligible for the
present prospective study if the following inclusion cri-
teria were fulfilled: age less than 18 years, Injury Severity
Score > 9 points [20,21], and consecutive admission to
the hospital’s pediatric intensive care unit. The data were
raised after inclusion by two independent reviewers
(MF and FH).
Demographics, injury severity and clinical course
Age and gender were measured as demographic parame-
ters. The overall injury severity was classified by the
established Injury Severity Score (ISS) basing upon the
Abbreviated Injury Scale (AIS, latest revision 2005), de-
termining the severity of individual injuries [22]. Clinical
course included duration of ventilation (hours), duration
of ICU treatment (days) and the overall length of stay
(LOS) in days.Multiple organ dysfunction syndrome and outcome
Organ function status was evaluated according to the
established score described by Marshall et al. [23] for at
least 14 days after hospital admission. In brief, five organ
dysfunctions (lung, liver, renal, hemodynamic and con-
sciousness) were scored daily from nought (no dysfunction)
to four points (severe dysfunction). Failure of organ func-
tion was considered at three or more points [23]; MODS
was defined as simultaneous failure of at least two organs
[8]. Children with development of MODS were assigned to
group I and with uneventful clinical course to group II.
Primary outcome was defined as MODS during clinical
course. Furthermore, mortality rate was evaluated by
this study.
Inflammatory marker
IL-6 [pg/ml] was measured with blood samples taken
during stabilization in the emergency department after
hospital admission. These samples represent the immuno-
logical response to trauma before emergency surgery was
initiated (day 1). During the intensive care treatment,
blood samples were taken repetitively every morning at
07:00 a.m. for at least 14 days. The IL-6 samples were part
of the daily routine performed at the Center of Laboratory
Medicine, Hannover Medical School, Hannover, Germany.
Therefore, there was no need for special blood collection
for this study. The measurement of IL-6 was performed
with the IMMULITE 2000 XPi Immunoassay System©,
Siemens AG©, Healthcare Sector, Erlangen, Germany.
Statistics
The data were analyzed using the Statistical Package for
the Social Sciences (SPSS; version 22; IBM Inc., Somers,
NY, USA).
Incidences are presented with counts and percentages
while continuous values are presented as arithmetic
mean and standard deviation (SD). IL-6 levels are pre-
sented as median with 25- and 75-interquartile ranges
(IQR 25 - 75). Apriori, Kolmogorow-Smirnow-Test was
used to evaluate whether the variables were distributed
normally. Differences between the groups were evaluated
with Student’s t-test (ISS) or Wilcoxon rank sum test
(Age, AIS distribution, treatment duration, IL-6 levels)
for continuous data, while Pearson’s χ2-test was used for
categorical variables. The Spearman rank correlation co-
efficient was used to determine the connection between
IL-6 levels and the injury severity as well as the deve-
lopment of MODS. In addition, Pearson’s correlation
was used to evaluate the linear relationship between these
variables. Finally, a “Receiver Operating Characteristic”
(ROC) analysis was performed to calculate the sensitivity
and specificity of IL-6 towards the incidence MODS.
A two sided p-value < 0.05 was considered to be
significant.
Table 1 Demographic parameters, injury distribution and
injury severity compared between children with






Group I Group II
Number of patients % (n) 11.9% (7) 88.1% (52) -
Age (years) 0.847
Mean ± SD 8.7 ± 4.7 8.4 ± 4.4
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Demographic data
In total, 59 traumatized children with a mean ISS of
23.9 ± 11.9 points were treated during the study period.
The mean age for all patients was 8.4 ± 4.4 years, and
57.6% were male (n = 34). Referring to the complication
of interest, 11.9% children (n = 7) developed MODS.
Overall mortality was 3.4% (n = 2) due to multiple organ
failure.Median [IQR 25-75] 7 [6-13] 9 [5-12]
Gender (♂ : ♀) 5 : 2 29 : 23 0.431
AIS head 0.818
Mean ± SD 2.9 ± 2.7 2.6 ± 1.8
Median [IQR 25-75] 5 [0-5] 4 [0-5]
AIS chest 0.158
Mean ± SD 2.3 ± 1.3 1.5 ± 1.7
Median [IQR 25-75] 2 [2-3] 2 [1-3]Multiple organ dysfunction syndrome and outcome
No differences were found referring to age, gender,
injury distribution or overall injury severity between chil-
dren with and without development of MODS (Table 1).
However, development of MODS lead to increased dur-
ation of ventilation, intensive care treatment as well as the
overall length of stay (Table 1). Mortality was only found
in patients with MODS (n = 2).AIS abdomen 0.534
Mean ± SD 1.4 ± 1.8 1.1 ± 1.4
Median [IQR 25-75] 0 [0-3] 0 [0-2]
AIS extremities 0.935
Mean ± SD 1.0 ± 1.2 1.0 ± 1.2
Median [IQR 25-75] 1 [0-2] 1 [0-2]
ISS 0.227
Mean ± SD 29.0 ± 7.4 23.3 ± 12.3
Median [IQR 25-75] 29 [25-38] 24 [13-29]
Duration of ventilation (hours) 0.001
Mean ± SD 418.7 ± 584.7 99.7 ± 133.5
Median [IQR 25-75] 249 [90-344] 27 [0-183]
Intensive care treatment (days) 0.003
Mean ± SD 21.1 ± 22.2 7.9 ± 8.3
Median [IQR 25-75] 15 [7-21] 5 [2-11]
Overall length of stay (days) 0.010
Mean ± SD 27.0 ± 21.8 14.3 ± 10.1
Median [IQR 25-75] 19 [10-41] 12 [8-19]
Mortality % (n) 28.6% (2) 0.0% (0) -Inflammatory marker
The descriptive course of systemic IL-6 levels compar-
ing children with MODS versus those with uneventful
clinical course is illustrated in Figure 1. In summary,
traumatized children with development of MODS have
been admitted with an increased mean IL-6 compared
to children with uneventful healing (group I: 86 pg/ml
[IQR 73-633 pg/ml] vs. group II: 57 pg/ml [IQR 20-
125 pg/ml]; p = 0.045) (Figure 1). On day two, plasma
IL-6 levels were increased in children developing
MODS (group I: 2614 pg/ml [IQR 624-4609 pg/ml] vs.
group II: 57 pg/ml [IQR 25-118 pg/ml]; p < 0.001). After
a considerable decrease on day three (group I: 252 pg/ml
[IQR 177-424 pg/ml] vs. group II: 23 pg/ml [IQR 11-
64 pg/ml]; p = 0.054), no further differences could be
measured for the further clinical course (p > 0.05).
Emphasizing on the potential prognostic value of IL-6,
the evaluated IL-6 levels were correlated with the injury
severity and the incidence of MODS (Table 2). While in-
creased IL-6 levels during hospital admission were asso-
ciated with the injury severity (r = 0.522, p < 0.001), any
association to the incidence of MODS could not be
shown at this time (r = 0.180, p = 0.231). However, in-
creased IL-6 levels on the following two days were no
longer associated with injury severity (day 2: r = 0.253,
p = 0.106; day 3: r = 0.061, p = 0.718) but a significant
correlation to the incidence of MODS was present on day 2
and 3 (day 2: r = 0.445, p = 0.003; day 3: r = 0.437, p = 0.007).
According to Pearson’s correlation demonstrated in Table 3
a slightly different result is presented with increased IL-6
values on admission being correlated to MODS as well.
According to ROC analysis IL-6 values on day 2 pre-
sented an area under the curve (AUC) of 0.921 towards
MODS (p = 0.021) (Figure 2).Discussion
The incidence of post-injury multiple organ failure in trau-
matized children has been described lower than in adults
[7]. However, this considerable clinical complication
leads to a consequent mortality up to 50% in children as
well [8]. Based on epidemiological studies regarding the
incidence of pediatric multiple organ failure differences
in the inflammatory response to trauma in children
compared to adults can be suggested [9]. Nevertheless,
clinical laboratory data of cytokine levels for pediatric
trauma are still lacking [10]. Therefore, we intended to
Figure 1 The course of IL-6 comparing children with and without MODS. Legend: abscissa: days. ordinate: IL-6 pg/ml. Significant differences
were found at day 1 and 2 between the groups.
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children in order to verify if considerable coherences simi-
lar to traumatized adults exist.
The results of the present study could be summarized
as follows:
11.9% of included children developed MODS with a
subsequent mortality of 28.6%.Table 2 Correlation of systemic plasma IL-6 values with
injury severity and the incidence of MODS during the
clinical course
Correlation coefficient Correlation coefficient
Injury severity (ISS) MODS incidence
Day 1 (Admission) 0.522* 0.180
Day 2 0.253 0.445*
Day 3 0.061 0.437*
Day 4 -0.126 0.295
Day 5 0.001 0.495**
Day 6 -0.156 0.047
Day 7 -0.123 0.043
Day 8 0.081 0.296
Day 9 0.189 0.210
Day 10 -0.172 0.112
Day 11 0.002 0.035
Day 12 0.334 -0.494
Day 13 0.227 -0.323
Day 14 0.521 -0.829
(Spearman rank correlation; *p < 0.01, **p < 0.05).No influence of age, gender, injury distribution or injury
severity could be shown. Children with development of
MODS had significantly increased IL-6 levels during the
first two days. Increased IL-6 levels during hospital admis-
sion were associated with injury severity, while an incon-
sistent association towards the development of MODS was
proven at hospital admission. Increased IL-6 levels on dayTable 3 Correlation of systemic plasma IL-6 values with
injury severity and the incidence of MODS during the
clinical course
Correlation coefficient Correlation coefficient
Injury severity (ISS) MODS incidence
Day 1 (Admission) 0.331* 0.297**
Day 2 0.115 0.717*
Day 3 -0.069 0.320
Day 4 -0.170 0.284
Day 5 -0.041 0.598*
Day 6 -0.107 -0.097
Day 7 -0.181 -0.196
Day 8 0.135 0.206
Day 9 0.196 -0.085
Day 10 0.015 -0.122
Day 11 0.112 -0.089
Day 12 0.192 -0.410
Day 13 0.124 -0.197
Day 14 0.195 -0.301
(Pearson correlation; *p < 0.01, **p < 0.05).
Figure 2 ROC-analysis of IL-6 towards MODS on the first three days.
Andruszkow et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2014, 22:16 Page 5 of 8
http://www.sjtrem.com/content/22/1/162 and 3 were no longer associated with injury severity, but
a correlation to the development of MODS was present.
The epidemiology of MODS in children has been
described in various clinical settings including children
with sepsis, congenital heart diseases as well as organ
and bone marrow transplantations [8,9,11,24-26]. Accor-
ding to these settings, an incidence of MODS between
4% and 90% was demonstrated [8,9,11,24-26]. However,
data about incidences of MODS in severely traumatized
children are very sparse with only one clinical trial by
Calkins et al. [7]. Retrospectively, the authors found only
3% of their severely traumatized children developing
MODS. The authors suggested that traumatized children
might be protected from sustaining this considerable
complication compared to adults. Speculations were made
if the lower incidence may be based upon a different
immune response to trauma or if the hormonal milieu of
children influences MODS and subsequently mortality.
The interested and critical readership responded thatchildren have closer monitoring of their fluid resuscitation
and thus less fluid overload-induced lung injury determined
the low incidence of MODS [27]. Furthermore, injury dis-
tributions as well as co-morbidities in the adult counterpart
were listed as potential reasons for the decreased incidences
of MODS [28]. However, the lack of current research leaves
space for speculations about the reduced incidence of
MODS in traumatized children.
Nevertheless, the detailed analysis of the immune
response to trauma in adults [13] suggests that immune
mediators might play a pivotal role in traumatized
children as well [10]. This hypothesis is supported by
findings of Zingarelli et al., who validated an age-related
susceptibility for hemorrhagic shock-induced acute lung
injury and SIRS in a rat model [29]. Systemic and end-
organ manifestations of uncontrolled inflammation were
regulated by peroxisome proliferator-activated receptor
gamma. Regulation of this receptor was age-related atte-
nuating the inflammatory response if administered in
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clinical study, circulating cytokines in adults and children
with burn injury were measured [30]. Systemic levels of
several mediators, e.g. IFN-γ, IL-10, IL-17, IL-4, IL-6, and
IL-8, were increased in adults compared to children [30].
The authors concluded that discrepancies between chil-
dren and adults suggest age-dependent therapeutic inter-
ventions to achieve attenuation of the inflammatory
response. As demonstrated by Finnerty et al., various la-
boratory parameters can be applied including pro- and
anti-inflammatory parameters [30]. Furthermore, alarmins
have been demonstrated to be involved in the early im-
mune response after trauma [31]. These include heat
shock proteins, annexins, defensins, and the high mobility
group Box 1 (HMGB1) [31]. Especially HMGB1 is cur-
rently in the focus regarding the very early stage of trigger-
ing a sterile inflammation within 30 minutes after trauma
[31]. In this respect, HMGB1 is stimulating macrophages
and endothelial cells to release TNF-alpha, IL-1 and IL-6
[31]. Arguing on daily clinical practice, IL-6 has been the
most useful and widely employed mediator because of its
plasma half life and relatively consistent release pattern in
posttraumatic inflammatory research [32]. Consequently,
we intended to evaluate the established IL-6 in severely
traumatized children: The present study shows a consider-
able correlation between IL-6 levels and development of
multiple organ failure after trauma in children confirming
results from other investigations in adults [17,32,33]: In a
prospective study analyzing 75 severely injured adult pa-
tients, plasma IL-6 levels were increased in MODS pa-
tients during the first 10 days [33]. In contrast to the
present study, the highest measured values were
noted on admission with a continuous decrease dur-
ing the following ten days. Furthermore, Giannoudis
et al. elucidated increased levels of IL-6 in severely
injured patients on the first five days in the presence of
MODS [32]. With an increase of plasma IL-6 levels on the
first day after admission and a subsequent decrease on the
following days, the descriptive IL-6 course in adults with
MODS was similar to the results of the present study.
However, emphasizing on the quantitative levels of IL-6,
we found increased levels (hospital admission: mean IL-6
2,616.3 pg/ml) in our pediatric population compared to
the aforementioned studies in adults (mean IL-6 1,000 pg/
ml) [17,32]. Surprisingly, this ratio is in contrast to the in-
flammatory reaction described after burn injury showing
increased levels in adult patients [30]. In accordance with
our results, children with isolated traumatic brain injury
showed significantly increased plasma IL-6 levels [34]
compared with adults [35]. Moreover, in the early post-
traumatic period (first 24 hours after head injury), the sys-
temic levels of IL-6 appeared to be increasing in pediatric
patients similar to findings in our study [34]. This
phenomenon was particularly evident in those childrenwith worse outcome [34]. Consequently, one might con-
clude that the inflammatory reaction to blunt trauma dif-
fers as compared to burn injuries. This suggestion is
supported by an immunological study evaluating pediatric
and adult immune responses to infectious impacts [36]:
No differences between pediatric and adult interleukin
levels were provided although correlations to worse out-
come were proven [36]. Based on these results we suggest
that the pediatric immune response to trauma seems
more sensitive compared to adults resulting in increased
cytokine levels. Interestingly, the measured correlation of
IL-6 and the incidence of MODS on the second and third
day is congruent to the elucidated prognostic time frame
in adults: With an increase of IL-6 during the first days,
some authors stated that the prognostic period of IL-6
ends after three days, indicating that IL-6 levels have no
prognostic value after that time point [33,37]. However,
since pediatric trauma leads to increased plasma IL-6
levels but has a lower incidence of MODS as compared
to adults, increased cytokine levels do not necessarily de-
termine an increased incidence MODS. One might
hypothesize that the cellular reaction and consequent
cytotoxic effect to the inflammatory impact could be less
severe than in adults. Further investigations of the cellular
and molecular mechanisms in the posttraumatic pediatric
inflammatory response are necessary to elucidate the role
of cytokines and related systemic consequences. Especially
research on complement and alarmin trigger mechanisms
could potentially reveal a different endogenous mechan-
ism of stimulation of macrophages and endothelial cells in
pediatric trauma patients. Although the measurement of
HMGB1 and toll-like receptors as initiators and modu-
lators of cytokine release seems impracticable for daily
clinical routine these parameters could help to understand
the dynamic of pediatric inflammatory response after
trauma.
Beside the discussed association of IL-6 levels towards
the incidence of MODS, IL-6 is commonly known to
describe the severity of trauma as well. Gebhard and
colleagues evaluated plasma IL-6 levels hourly after severe
trauma in 94 traumatized adult patients [18]. Their results
revealed an early increase immediately after trauma. Over-
all, the best correlation of IL-6 release with the ISS values
was described during the first 6 hours after hospital
admission which seems congruent with our results. In
addition, Strecker et al. prospectively evaluated 107 trau-
matized adult patients collecting blood samples on ad-
mission until the 10th day after trauma [38]. Similar to the
presented results, correlation between systemic plasma
IL-6 levels and the ISS succeeded only within the first
24 hours after admission. However, the presented study is
the first demonstrating a correlation of increased IL-6
values with the extent of trauma in children. Similar
to previous results in adult patients, increased IL-6
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period.
The presented analysis has several notable limitations.
Critics to the presented study could be remarked due to
the fact that the MODS score used has not been validated
in children. Yet, other commonly used scoring systems
have the same limitations [39,40]. Referring to Calkins
et al. [7], the currently established pediatric scoring systems
[41,42] do not differentiate between previously healthy
trauma patients and children with life threatening chronic
diseases. Thus, pediatric organ dysfunction scoring in trau-
matized patients remains to be defined [7]. According to
the presented results, support of organ function, e.g. venti-
lation support and dialysis, was performed by the treating
ICU team in MODS patients as defined in our study.
Apriori, the small number of patients limits the statistical
power although this number seems comparable to pro-
spective studies in adults [17,33]. However, the incidence
of pediatric patients suffering from major trauma is rather
low; thus, multi-center studies with other limitations are
required to reasonably increase patients’ number. Referring
to the inclusion criteria of an ISS > 9 points we feel safe to
describe our study population severely injured due to the
measured mean ISS of approximately 24 points which is
comparable to the study population by Calkins et al., who
demonstrated a mean ISS of 26 points despite the inclusion
criteria of ISS >15 [7]. However, the most considerable
limitation is the lack of a comparative adult trauma po-
pulation. In order to enable direct comparison between
children and adults, further research in similar settings is
needed to guarantee an adequate perception.
Despite these limitations, this article does elucidate
that IL-6 after pediatric trauma is associated with an
increased risk of MODS.
Conclusions
The relationship between clinical and laboratory evaluation
of systemic inflammation has been described in adult
trauma patients evaluating IL-6 as most reliable marker.
The presented prospective study is now the first providing
evidence of a correlation of systemic IL-6 levels with injury
severity and the incidence of MODS in pediatric trauma
patients. Further studies are required to elucidate prognos-
tic levels of IL-6 and to determine the effect of inflamma-
tory mediators following trauma in children.
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